ESPR - CIK 0001434868
Esperion Therapeutics, Inc. has filed 885 documents with the SEC between 2008 and 2026. The most frequent type is insider trade (331 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2026-05-08 | 2026-03-31 |
| Proxy materials | DEFA14A | 2026-05-04 | - |
| Proxy materials | DEFA14A | 2026-05-01 | - |
| Proxy materials | DEFA14A | 2026-05-01 | - |
| Major company event | 8-K | 2026-05-01 | 2026-05-01 |
| SCHEDULE 13G | - | 2026-04-22 | - |
| Annual report to shareholders | ARS | 2026-04-16 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-16 | - |
| Proxy statement | DEF 14A | 2026-04-16 | 2026-04-16 |
| Major company event | 8-K | 2026-04-02 | 2026-04-02 |
| SCHEDULE 13G/A | - | 2026-03-26 | - |
| Insider trade | 4 | 2026-03-18 | 2026-03-17 |
| Insider trade | 4 | 2026-03-18 | 2026-03-17 |
| Insider trade | 4 | 2026-03-18 | 2026-03-17 |
| Insider sale notice | 144 | 2026-03-17 | - |
| Insider sale notice | 144 | 2026-03-17 | - |
| Insider sale notice | 144 | 2026-03-17 | - |
| Insider trade | 4 | 2026-03-16 | 2026-03-13 |
| Insider trade | 4 | 2026-03-16 | 2026-03-13 |
| Insider trade | 4 | 2026-03-16 | 2026-03-13 |
| Annual report | 10-K | 2026-03-10 | 2025-12-31 |
| Major company event | 8-K | 2026-03-10 | 2026-03-10 |
| Major company event | 8-K | 2026-03-03 | 2026-03-02 |
| Insider trade | 4 | 2026-01-21 | 2026-01-20 |
| Insider sale notice | 144 | 2026-01-20 | - |
| Major company event | 8-K | 2026-01-12 | 2026-01-11 |
| Insider trade | 4 | 2025-12-18 | 2025-12-17 |
| Insider trade | 4 | 2025-12-18 | 2025-12-17 |
| Insider trade | 4 | 2025-12-18 | 2025-12-17 |
| Insider sale notice | 144 | 2025-12-17 | - |
| Insider sale notice | 144 | 2025-12-17 | - |
| Insider sale notice | 144 | 2025-12-17 | - |
| Insider trade | 4 | 2025-12-08 | 2025-12-04 |
| New insider ownership | 3 | 2025-11-17 | 2025-11-17 |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-12 | - |
| Quarterly report | 10-Q | 2025-11-06 | 2025-09-30 |
| Major company event | 8-K | 2025-11-06 | 2025-11-06 |
| Major company event | 8-K | 2025-11-04 | 2025-11-04 |
| Insider trade | 4 | 2025-10-20 | 2025-10-17 |
| Insider sale notice | 144 | 2025-10-17 | - |
| Major company event | 8-K | 2025-10-08 | 2025-10-07 |
| Prospectus supplement | 424B5 | 2025-10-08 | - |
| Prospectus supplement | 424B5 | 2025-10-07 | - |
| Major company event | 8-K | 2025-10-07 | 2025-10-07 |
| Insider trade | 4 | 2025-09-18 | 2025-09-17 |
| Insider trade | 4 | 2025-09-18 | 2025-09-17 |
| Insider trade | 4 | 2025-09-18 | 2025-09-17 |
| Insider sale notice | 144 | 2025-09-17 | - |
| Insider sale notice | 144 | 2025-09-17 | - |